Scientific publications

Diagnostic protocol for cardiomyopathy secondary to cancer treatments

Nov 1, 2017 | Magazine: Medicine (Spain)

T.López-Fernández, M.Canales Albendea, A.Buño Soto, J.Feliu, I.Rodríguez, M.Moreno Yangüela, J.L.López Sendón

The term cardio-oncology refers to monitoring and risk stratification throughout the stages of cancer, to minimize or eliminate cardiovascular complications, as well as early termination of potentially curative treatments.

These objectives can only be achieved with a multidisciplinary approach. The development of local monitoring protocols that adapt the general recommendations to the means available in each centre is a critical step in the management of cardiotoxicity.

The protocol for the prevention and early diagnosis of cardiomyopathy secondary to cancer treatments of the Cardio-Oncology Unit of University Hospital La Paz is summarized below.

CITATION  Pediatr Blood Cancer. 2015 May;62(5):867-74. doi: 10.1002/pbc.25381. Epub 2015 Jan 16

Our authors